GABA and neuropsychiatric disorders.
D000818:Animals; D001479:Basal Ganglia / Q000032:analysis; D002493:Central Nervous System Diseases / Q000188:drug therapy; D004831:Epilepsies, Myoclonic / Q000378:metabolism; D004828:Epilepsies, Partial / Q000378:metabolism; D000882:Haplorhini; D006801:Humans; D006816:Huntington Disease / Q000378:metabolism; D001523:Mental Disorders / Q000378:metabolism*; D009422:Nervous System Diseases / Q000378:metabolism*; D011618:Psychotic Disorders / Q000378:metabolism; D012640:Seizures / Q000378:metabolism; D013378:Substantia Nigra / Q000032:analysis; D005680:gamma-Aminobutyric Acid / Q000032:analysis / Q000378:metabolism* / Q000627:therapeutic use
D005680:gamma-Aminobutyric Acid